Vaccine and treatment evaluation units (VTEU) protocol development, implementation and assays task area B-D phase 1 PK trial to evaluate fosfomycin task order 16-0058.B1C1D1.0076

Ended Awarded Last action

Contract number
HHSN27200022
Awardee
Awarding agency
Obligated
$1,222,392

Award facts

Opportunity
Contract value 100% obligated
$1,222,392.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Durham, NC 27705, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00008 $0
Other Administrative Action P00007 $0
Supplemental Agreement for work within scope P00006 $31,500
Supplemental Agreement for work within scope P00005 $29,154
Supplemental Agreement for work within scope P00004 $0
Supplemental Agreement for work within scope P00003 $45,023
Supplemental Agreement for work within scope P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $1,116,715

About this award

This contract was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Duke University Office of Research Administration Division. The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which focuses on developing and evaluating vaccines and treatments. This specific task order, valued at $1,222,392.00, is for protocol development, implementation, and assays for a Phase 1 pharmacokinetic trial to evaluate the antibiotic fosfomycin. The contract is a delivery order with a cost-no-fee pricing type and a completion date of October 31, 2023. No set-aside designation was used for this award. As a private research university, Duke University has extensive experience conducting clinical research and providing immunization safety assessment services under federal contracts and grants.

Quick answers

Who was awarded contract HHSN27200022?

HHSN27200022 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 17, 2017.

How much is contract HHSN27200022 worth?

The government has obligated $1,222,392 on HHSN27200022.

Is contract HHSN27200022 an order under another contract?

Yes. HHSN27200022 is a delivery order under HHSN272201300017I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).

Was contract HHSN27200022 competed?

The extent of competition for HHSN27200022 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award